ASND (Ascendis Pharma A/S) Stock Market Reviews

crown

search

Read and share opinions on ASND (Ascendis Pharma A/S) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ASND

Ascendis Pharma A/S

clarify Biotechnology

bookmark Healthcare

public Denmark

Sell Neutral Buy

Latest News

A Look at Ascendis Pharma (NasdaqGS:ASND) Valuation Following Q3 Growth and Pipeline Progress
Nov 14, 2025
Ascendis Pharma AS (ASND) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Nov 13, 2025
Ascendis Pharma Reports Third Quarter 2025 Financial Results
Nov 12, 2025
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism
Nov 7, 2025
Ascendis Pharma to Report Third Quarter 2025 Financial Results and Provide Business Update on November 12, 2025
Nov 5, 2025
3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon® PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025
Nov 3, 2025
Ascendis Pharma (NasdaqGS:ASND): Evaluating Valuation After Sharply Higher Share Price This Quarter
Oct 16, 2025
Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon® CNP for Treatment of Children with Achondroplasia
Oct 8, 2025

Reviews